Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACRX - AcelRx Pharmaceuticals Inc. (ACRX) CEO Vincent Angotti on Q1 2022 Results - Earnings Call Transcript

ACRX - AcelRx Pharmaceuticals Inc. (ACRX) CEO Vincent Angotti on Q1 2022 Results - Earnings Call Transcript

AcelRx Pharmaceuticals Inc.
AcelRx Pharmaceuticals, Inc. (ACRX) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Raffi Asadorian - Chief Financial Officer Vincent Angotti - Chief Executive Officer Pamela Palmer - Chief Medical Officer and Co-Founder Conference Call Participants Brandon Folkes - Cantor Fitzgerald Thomas Yip - H.C. Wainwright Robert LeBoyer - Noble Capital Presentation Operator Welcome to the AcelRx First Quarter, 2022 Earnings Call. This call is being webcast live on the events page of the investors section of AcelRx's website at www.acelrx.com. This call is the property of AcelRx and any recording, reproduction, or transmission of this call without the expressed written consent of AcelRx is strictly prohibited. [Operator Instructions] As a reminder, today's call is being recorded. You may listen to a webcast replay of this call by going to the investors section of AcelRx 's website. I would now like to turn the call over

For further details see:

AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: AcelRx Pharmaceuticals Inc.
Stock Symbol: ACRX
Market: NASDAQ
Website: acelrx.com
Menu
ACRX ACRX Quote ACRX Short ACRX News ACRX Articles ACRX Message Board
Get ACRX Alerts

News, Short Squeeze, Breakout and More Instantly...